Filing Flows › Rapid Micro Biosystems (RPID) › Q2 2026
Rapid Micro Biosystems (RPID) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 7, 2026
Rapid Micro Biosystems (RPID) reported revenue of $8.1M for the second quarter 2026 (Q2 2026), +11% from a year earlier and +0.6% from the quarter before. Operating margin was -153.0%, net loss $12.9M (160.5% of revenue).
Rapid Micro Biosystems, Q2 2026: revenue $8.1M (+11% year over year), operating margin -153.0%, net loss $12.9M, operating cash flow −$12.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.1M | +0.6% | +11% |
| Operating profit | −$12.3M | — | — |
| Net earnings | −$12.9M | — | — |
| Operating cash flow | −$12.7M | — | — |
What changed
Revenue was $8.1M in Q2 2026, up 11% year over year and up 1% from the previous quarter. Product was the largest line at 66% of revenue. Product added $484K year over year (up 10%), 61% of the total change.
Gross margin was 15.0%, up 11.3 points from Q2 2025. Operating costs exceeded revenue by $12.3M, an operating margin of -153.0%. Operating expenses grew 9% against revenue growth of 11%. The fastest-growing cost line was General & admin (+11%). The quarter ended with a net loss of $12.9M, narrower than the previous quarter's $14.3M loss.
Operating cash flow was −$12.7M. Non-cash charges added back $674K of depreciation and amortization and $1.3M of share-based compensation. Working capital and other items used $1.8M. Capital expenditures of −$223K exceeded it, leaving free cash flow of −$12.5M.
Questions
What was Rapid Micro Biosystems' revenue in the second quarter 2026?
Rapid Micro Biosystems (RPID) reported revenue of $8.1M for the second quarter 2026 (Q2 2026), +11% from a year earlier and +0.6% from the quarter before.
Was Rapid Micro Biosystems profitable in the second quarter 2026?
Operating loss was $12.3M (-153.0% of revenue) and net loss $12.9M.